Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-09-01Clinical Trial Update: Auditory Brainstem Response as a Diagnostic Tool in Schizophrenia and Bipolar Disorder
A completed clinical trial evaluated auditory brainstem response as a diagnostic tool for schizophrenia and bipolar disorder.
-
CLINICAL_TRIALS trial_result · 2015-08-31Clinical Trial Update: A Study of the Efficacy and Safety of Asenapine in Participants With an Acute Exacerbation of Schizophrenia (P05688) [Phase 3]
Clinical trial update reporting the completion of a Phase 3 study evaluating the efficacy and safety of asenapine in adults with acute exace…
-
CLINICAL_TRIALS trial_result · 2015-08-26Clinical Trial Update: Long-term Study of Asenapine in Participants With Residual Subtype, Receiving Multiple or/and High Dose Drugs, or Treatment Refractory Schizophrenia (P06238) [Phase 3]
Phase 3 long-term study of asenapine in adults with residual schizophrenia or treatment-refractory schizophrenia; results were posted in 201…
-
CLINICAL_TRIALS trial_result · 2015-08-25Clinical Trial Update: Effects of Varenicline on Plasticity in Schizophrenia [Phase 2]
Phase 2 trial completed evaluating varenicline for effects on plasticity in schizophrenia.
-
CLINICAL_TRIALS trial_result · 2015-08-24Clinical Trial Update: A Study of Usage of Paliperidone Palmitate in Patients With Schizophrenia in a Hospital Setting
A completed clinical trial evaluating the usage of paliperidone palmitate for schizophrenia in a hospital setting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-08-21Clinical Trial Update: MK0557 for the Treatment of Cognitive Impairment in Patients With Schizophrenia (0557-027) [Phase 2]
Completed Phase 2 clinical trial of MK0557 for cognitive impairment in schizophrenia, including paranoid schizophrenia, sponsored by Merck S…
-
CLINICAL_TRIALS trial_result · 2015-08-17Clinical Trial Update: Interest of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Auditory Hallucinations [Phase 2]
This update notes the completion of a Phase 2 study evaluating repetitive transcranial magnetic stimulation (rTMS) for auditory hallucinatio…
-
CLINICAL_TRIALS trial_result · 2015-08-11Clinical Trial Update: Assessing the Impact of Self-directed Care, Within a Medicaid-funded Environment,on Participation and Community Living [NA]
Completed clinical trial update evaluating the impact of self-directed care in a Medicaid-funded environment on participation and community …
-
CLINICAL_TRIALS trial_result · 2015-08-10Clinical Trial Update: Cognitive Behavioral Therapy for Post-Traumatic Stress Disorder in Individuals With Severe Mental Illness [Phase 2]
Phase 2 results from a cognitive behavioral therapy intervention for post-traumatic stress disorder in individuals with schizophrenia or oth…
-
CLINICAL_TRIALS trial_result · 2015-07-30Clinical Trial Update: An Open Study of Sulforaphane-rich Broccoli Sprout Extract in Patients With Schizophrenia [Phase 2]
A Phase 2 open study evaluating sulforaphane-rich broccoli sprout extract in patients with schizophrenia has completed at Chiba University.
-
CLINICAL_TRIALS trial_result · 2015-07-30Clinical Trial Update: 20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms [Phase 2]
A Phase 2 trial evaluating AMG 747 for negative symptoms in schizophrenia was terminated.
-
CLINICAL_TRIALS trial_result · 2015-07-16Clinical Trial Update: Randomized, Controlled, Double Blind Trial of Eszopiclone for Insomnia Associated With Schizophrenia [NA]
A randomized, double-blind trial evaluated eszopiclone for insomnia in individuals with schizophrenia, with results posted in July 2015.
-
CLINICAL_TRIALS trial_result · 2015-07-10Clinical Trial Update: Assessing the Effects of Fanapt® on Social Cognition in Schizophrenia [Phase 4]
A Phase 4 trial evaluating the effects of Fanapt (iloperidone) on social cognition in schizophrenia and schizoaffective disorder; the study …
-
CLINICAL_TRIALS trial_result · 2015-07-01Clinical Trial Update: Investigation of the Drug Dimethoxbenzylidene Anabaseine in Treating Schizophrenia Patients [Phase 1]
Phase 1 study of Dimethoxbenzylidene Anabaseine in patients with schizophrenia and psychotic disorders has completed. The update notes compl…
-
CLINICAL_TRIALS trial_result · 2015-06-24Clinical Trial Update: Treatment of Antipsychotic-associated Obesity With a GLP-1 Analogue [Phase 3]
Phase 3 trial evaluating liraglutide, a GLP-1 analogue, for antipsychotic-associated obesity and metabolic syndrome in schizophrenia; the st…
-
CLINICAL_TRIALS trial_result · 2015-06-24Clinical Trial Update: Study of the Effect of Single Doses of MK2637 and Dextromethorphan on Cerebral Cortex Excitability (2637-008) [Phase 1]
This Phase 1 trial evaluated the effects of single doses of MK2637 and dextromethorphan on cerebral cortex excitability in schizophrenia. Th…
-
CLINICAL_TRIALS trial_result · 2015-06-23Clinical Trial Update: Smoking Cessation for Veterans With Severe and Persistent Mental Illness [Phase 2, Phase 3]
This is a Phase 2/3 clinical trial results update from the US Department of Veterans Affairs on smoking cessation for veterans with severe a…
-
CLINICAL_TRIALS trial_result · 2015-06-23Clinical Trial Update: Influence of Acupuncture on Emotional Measures and Quality of Sleep Among Schizophrenia Patients [NA]
Completed clinical trial evaluating whether acupuncture influences emotional measures and sleep quality in patients with schizophrenia or sc…
-
CLINICAL_TRIALS trial_result · 2015-06-22Clinical Trial Update: Clinical Effectiveness of Newer Antipsychotics in Comparison With Conventional Antipsychotics in Schizophrenia [Phase 4]
A Phase 4 clinical trial update evaluating the effectiveness of newer antipsychotics in comparison with conventional antipsychotics for schi…
-
CLINICAL_TRIALS trial_result · 2015-06-18Clinical Trial Update: A Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Patients With Schizophrenia [Phase 3]
Phase 3 study of paliperidone palmitate 3-month formulation for schizophrenia has completed. Results were posted on June 18, 2015.
-
CLINICAL_TRIALS trial_result · 2015-06-18Clinical Trial Update: An Randomized Open-Label PK Study of LY03004 Compared to Risperdal® Consta® in Stable Patients With Schizophrenia or Schizoaffective Disorder [Phase 1]
A Phase 1 randomized open-label pharmacokinetic study comparing LY03004 with Risperdal Consta in stable patients with schizophrenia or schiz…
-
CLINICAL_TRIALS trial_result · 2015-06-17Clinical Trial Update: CATIE- Schizophrenia Trial [Phase 4]
CATIE, a Phase 4 schizophrenia trial sponsored by the National Institute of Mental Health, has completed its study.
-
CLINICAL_TRIALS trial_result · 2015-06-15Clinical Trial Update: Cognitive Adaptive Training for Improving Medication Adherence, Symptoms, and Function in People With Schizophrenia [NA]
This entry reports the completion and posted results of a clinical trial evaluating cognitive adaptive training to improve medication adhere…
-
CLINICAL_TRIALS trial_result · 2015-06-11Clinical Trial Update: Oxytocin Treatment of Social Cognitive and Functional Deficits in Schizophrenia [Phase 1]
A Phase 1 clinical trial evaluating oxytocin for social cognitive and functional deficits in schizophrenia (also applicable to schizoaffecti…
-
CLINICAL_TRIALS trial_result · 2015-06-10Clinical Trial Update: Supported Employment and Skills Training in Conjunction With Pharmacotherapy in Schizophrenia Patients [Phase 4]
Phase 4 trial evaluating whether adding supported employment and skills training to ongoing pharmacotherapy improves outcomes in schizophren…